Crystalline form of lorlatinib free base Application US-10420749-B2 United States of America 24 Sep 2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrimidine derivatives and 2,3-dihydro-1H-imi… Application US-10342795-B2 United States of America 09 Jul 2019
Substituted 4,5,6,7-tetrahydro-pyrazolo[1,5-a]pyrazine derivatives and 5,6,7,8-tetrahydro-4… Application US-10280170-B2 United States of America 07 May 2019
Quinazolinone and isoquinolinone derivative Grant US-10005739-B2 United States of America 26 Jun 2018
METHOD FOR DETECTING A FIG-ROS FUSION POLYNUCLEOTIDE Application EP-3266795-A1 European Patent Office 10 Jan 2018
Solid forms of a macrocyclic kinase inhibitor Application US-9637500-B2 United States of America 02 May 2017
Anti-DDR1 antibody having anti-tumor activity Grant US-9550835-B2 United States of America 24 Jan 2017
Mutant ROS expression in human liver cancer Application EP-2881402-A1 European Patent Office 10 Jun 2015
CRIZOTINIB FOR USE IN THE TREATMENT OF CANCER Application WO-2013017989-A1 World Intellectual Property Organisation (WIPO) 07 Feb 2013